COMPANY

NGGT

HQ: Walnut Creek, CA source · nggtbio.com ↗

Keywords: gene therapy neurology metabolic ophthalmology neurodegenerative diseases Phenylketonurias NGGT002

Location: Walnut Creek, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Jan 10, 2025 Trial start Phase 1/Phase 2: AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom) source ↗

Dec 30, 2030 (ESTIMATED) · Phase 1/Phase 2 · AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom) · NCT06332807

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT06332807	AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)	Phase 1/Phase 2	Recruiting	Jan 10, 2025	Dec 30, 2030 (estimated)